Peptides Hormones · Supplementary · from Peptides Hormones

Case 2: Hypothalamic-Pituitary-Adrenal Axis Dysfunction

Patient Presentation

Demographics: 36-year-old female physician (emergency medicine resident)

Chief Complaint: "I can't function anymore. I crash in the afternoons, I can't handle stress like I used to, and I get dizzy every time I stand up."

History of Present Illness: The patient presents with a 2-year history of progressive fatigue, stress intolerance, and orthostatic symptoms in the context of chronic high-intensity work demands. She works 60-70 hour weeks including overnight shifts in a busy emergency department. She reports profound fatigue particularly between 2-4 PM and again at 8-9 PM, with paradoxical wakefulness at 11 PM-midnight making sleep initiation difficult.

She describes a markedly diminished ability to cope with stress that she previously managed well. Minor stressors now provoke disproportionate anxiety, irritability, or tearfulness. She reports salt cravings, frequent lightheadedness when standing from a seated position, and has nearly fainted twice in the past 3 months. She notes frequent non-specific infections (3 upper respiratory infections and 2 episodes of oral herpes in 6 months) and prolonged recovery times.

She has also developed diffuse myalgias, brain fog, and reactive hypoglycemia episodes (shakiness, confusion, and sweating 2-3 hours after meals, relieved by eating). She self-treats with frequent caffeine (6+ cups of coffee daily) and notes that her symptoms transiently improve with caffeine and worsen significantly during days off when she attempts to rest.

Past Medical History:

  • No formal diagnoses
  • History of high academic achievement and chronic overwork since medical school
  • Recurrent viral infections (increased frequency over 2 years)
  • Amenorrhea for 8 months (previously regular cycles)

Medications:

  • Oral contraceptive pill (combined ethinylestradiol/levonorgestrel) - recently stopped
  • Caffeine (estimated 600+ mg daily)
  • Melatonin 5 mg at bedtime intermittently

Social History:

  • Non-smoker, rare alcohol
  • No regular exercise (previously ran half-marathons)
  • Overnight shift work (rotating schedule)
  • Chronically sleep-deprived (averaging 4-5 hours per 24 hours)
  • Living alone, limited social connections due to schedule
  • Diet: erratic meal timing, high in processed food and caffeine

Family History:

  • Mother: Hashimoto thyroiditis
  • Father: Healthy
  • Sister: Addison disease (autoimmune)

Physical Examination

  • Vital Signs: BP 98/62 mmHg supine, 84/54 mmHg standing (orthostatic positive), HR 72 supine, 98 standing (orthostatic positive), RR 14, Temp 36.2°C, SpO2 99% RA, BMI 21.4
  • General: Thin, fatigued-appearing female with dark periorbital circles
  • Skin: Slight hyperpigmentation of palmar creases and buccal mucosa, dry skin, no striae
  • HEENT: Mild conjunctival pallor
  • Thyroid: Normal size, non-tender, no nodules
  • Cardiovascular: Regular, no murmurs, soft S1
  • Abdomen: Soft, non-tender, thin habitus
  • Musculoskeletal: Mild diffuse tenderness, reduced grip strength
  • Neurological: Normal cranial nerves, mildly delayed relaxation of ankle reflexes
  • Psychiatric: Flat affect, appears exhausted, speech slow and effortful

Workup and Results

Laboratory Studies:

TestResultReference Range
Cortisol (8 AM, non-shift day)4.8 mcg/dL6.2-19.4 mcg/dL
Cortisol (8 AM repeat)5.2 mcg/dL6.2-19.4 mcg/dL
ACTH (8 AM)48 pg/mL7-63 pg/mL
ACTH stimulation test (250 mcg cosyntropin): 0 min5.0 mcg/dL-
ACTH stimulation test: 30 min16.2 mcg/dL> 18 mcg/dL
ACTH stimulation test: 60 min17.8 mcg/dL> 18 mcg/dL
Low-dose (1 mcg) cosyntropin test: 30 min14.4 mcg/dL> 18 mcg/dL
DHEA-S42 mcg/dL95-530 mcg/dL
Salivary cortisol (4-point diurnal): Morning0.18 mcg/dL0.25-0.60 mcg/dL
Salivary cortisol: Noon0.14 mcg/dL0.10-0.30 mcg/dL
Salivary cortisol: Evening0.12 mcg/dL0.04-0.15 mcg/dL
Salivary cortisol: Night0.09 mcg/dL0.02-0.08 mcg/dL
24-hr urinary free cortisol18 mcg/24hr20-90 mcg/24hr
TSH4.8 mIU/L0.4-4.0 mIU/L
Free T40.9 ng/dL0.8-1.8 ng/dL
Free T32.0 pg/mL2.3-4.2 pg/mL
Anti-TPO antibodies186 IU/mL< 35 IU/mL
Anti-21-hydroxylase antibodiesNegativeNegative
CBCWBC 3.8, Lymphocytes 1.2WBC 4.5-11, Lymph 1.0-4.8
Sodium134 mEq/L136-145 mEq/L
Potassium4.8 mEq/L3.5-5.0 mEq/L
Fasting glucose68 mg/dL70-100 mg/dL
Aldosterone4.2 ng/dL3-16 ng/dL
Renin activity3.8 ng/mL/hr0.5-3.0 ng/mL/hr
Ferritin8 ng/mL12-150 ng/mL
Vitamin D16 ng/mL30-100 ng/mL
LH1.2 IU/L1.9-12.5 IU/L
FSH1.8 IU/L2.5-10.2 IU/L
Estradiol18 pg/mL21-312 pg/mL (follicular)

Imaging/Additional Studies:

  • DUTCH Complete Hormone Test: Flattened cortisol diurnal curve with blunted cortisol awakening response, low cortisol metabolites, reduced cortisone-to-cortisol ratio suggesting 11-beta-HSD1 dysregulation, low DHEA metabolites
  • MRI pituitary: Normal size and morphology, no adenoma
  • CT adrenals: Normal bilateral adrenal glands, no atrophy or masses
  • Thyroid ultrasound: Mild diffuse heterogeneity consistent with early thyroiditis, no nodules

Clinical Image

Diagram illustrating the spectrum of HPA axis dysfunction from normal stress response through maladaptive stages: initial hyperactivation with elevated cortisol, progression to blunted diurnal rhythm with preserved total output, and eventual hypothalamic downregulation with low cortisol output. Shows contributing factors including chronic stress, sleep deprivation, circadian disruption, and nutritional deficiency. Source: Educational illustration.

Diagnosis

Hypothalamic-Pituitary-Adrenal Axis Dysfunction with Suboptimal Cortisol Response, Functional Hypothalamic Amenorrhea, Early Hashimoto Thyroiditis, Iron Deficiency, and Vitamin D Deficiency

Key Diagnostic Criteria:

  • Low morning serum cortisol on two occasions (4.8 and 5.2 mcg/dL) with suboptimal (but not absent) cosyntropin response
  • Flattened salivary cortisol diurnal curve with blunted cortisol awakening response
  • Low urinary free cortisol (18 mcg/24hr)
  • Severely depressed DHEA-S indicating adrenal reserve depletion
  • Normal ACTH (not elevated as in primary Addison), negative anti-21-hydroxylase antibodies
  • Normal adrenal imaging excluding structural disease
  • Concurrent functional hypothalamic amenorrhea (low LH, FSH, estradiol) from chronic energy deficit and stress
  • Early Hashimoto thyroiditis (elevated TPO antibodies, borderline high TSH, low-normal free T3/T4)
  • Clear precipitating context: chronic sleep deprivation, circadian disruption, caloric insufficiency, and sustained psychological stress

Treatment Plan

  1. Foundational interventions (non-negotiable):
  • Work schedule modification: Formal occupational health referral; reduce to 50-hour maximum work weeks, eliminate consecutive overnight shifts, request minimum 48-hour recovery between night shifts; this is the root cause and must be addressed or treatment will fail
  • Sleep restoration: Sleep hygiene optimization, target 7-8 hours per 24 hours, blackout curtains, post-night shift sleep protocol, gradual caffeine taper to < 200 mg daily (morning only)
  • Nutritional rehabilitation: Regular meal timing every 3-4 hours, adequate caloric intake (minimum 2000 kcal/day), complex carbohydrates with protein at each meal to prevent reactive hypoglycemia, increase salt intake to 6-8 g/day for orthostatic support
  1. Adrenal support protocol:
  • Hydrocortisone 10 mg on waking + 5 mg at noon during recovery phase (physiologic replacement, not pharmacologic), taper over 8-12 weeks as HPA axis recovers
  • DHEA 25 mg daily morning (given severely depleted DHEA-S)
  • Adaptogenic herbs: Rhodiola rosea 200 mg morning + Ashwagandha 300 mg BID (evidence for HPA axis modulation)
  • Phosphatidylserine 300 mg at bedtime (blunts nocturnal cortisol and supports sleep)
  • Vitamin C 1000 mg daily (adrenal cortex has highest vitamin C concentration of any organ)
  1. Thyroid management:
  • Start levothyroxine 25 mcg daily given symptomatic subclinical hypothyroidism with positive antibodies, family history, and context (caution: do not start thyroid replacement before ensuring adequate cortisol, as T4 replacement increases cortisol metabolism)
  • Selenium 200 mcg daily (evidence for reducing TPO antibodies in Hashimoto)
  • Recheck TSH, free T4, free T3 at 6 weeks
  1. Nutritional deficiency correction:
  • Iron bisglycinate 45 mg daily with vitamin C (ferritin goal > 50)
  • Vitamin D3 5000 IU daily with K2
  • Magnesium glycinate 400 mg at bedtime
  1. Amenorrhea management:
  • Expected to resolve with caloric restoration, stress reduction, and cortisol normalization
  • If persistent at 6 months, consider pulsatile GnRH or low-dose estrogen replacement for bone protection
  • DEXA scan if amenorrhea persists > 12 months total
  1. Follow-up: Repeat morning cortisol, DHEA-S, and 4-point salivary cortisol at 8 weeks; TSH and free T4 at 6 weeks; ferritin and vitamin D at 8 weeks; menstrual diary; repeat cosyntropin test at 6 months

Key Learning Points

  • HPA axis dysfunction from chronic stress is a real clinical entity characterized by blunted cortisol diurnal rhythm and suboptimal (but not absent) stimulation test responses; it is distinct from Addison disease and requires different management
  • The low-dose (1 mcg) cosyntropin test is more sensitive than the standard 250 mcg test for detecting subtle adrenal insufficiency because it better simulates physiologic ACTH levels
  • DHEA-S is a sensitive marker of adrenal reserve that may decline before cortisol abnormalities become apparent; it serves as an early indicator of HPA axis strain
  • Levothyroxine should not be initiated in patients with concurrent cortisol deficiency without first addressing cortisol replacement, as thyroid hormone replacement increases cortisol clearance and can precipitate adrenal crisis
  • Functional hypothalamic amenorrhea, HPA axis dysfunction, and subclinical thyroiditis frequently co-occur in the setting of chronic stress and energy deficit, representing a systemic neuroendocrine adaptation rather than isolated organ dysfunction

All cases for this lecture as Markdown